Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma

  1. Genolla, J.
  2. Rodriguez, T.
  3. Minguez, P.
  4. Lopez-Almaraz, R.
  5. Llorens, V.
  6. Echebarria, A.
Aldizkaria:
European Journal of Nuclear Medicine and Molecular Imaging

ISSN: 1619-7089,  1619-7070

Argitalpen urtea: 2019

Alea: 46

Zenbakia: 7

Orrialdeak: 1567-1575

Mota: Artikulua

DOI: 10.1007/S00259-019-04291-X GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus